Virax Biolabs Group Accounts Payable

Virax Biolabs Group (VRAX) currently reports a accounts payable of $52K as of March 2026. That compares with $56K in the prior-year period — down 7.7% year over year. Use the charts on this page to explore Virax Biolabs Group's accounts payable history and peer comparisons.

Virax Biolabs Group's accounts payable decreased from $56K to $52K — a 7.7% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Virax Biolabs Group reported $52K in accounts payable as of March 2026. That compares with $56K in the prior-year period — down 7.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $52K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Virax Biolabs Group, and consider following VRAX for alerts when major investors trade the stock.